These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36650390)

  • 1. Understanding Barriers and Facilitators of Pre-exposure Prophylaxis (PrEP) Among Transgender and Gender Diverse Adults in an Integrated Health Care System.
    Bruxvoort K; Portugal C; Munis M; Pak K; Hechter R
    AIDS Behav; 2023 Aug; 27(8):2579-2591. PubMed ID: 36650390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators to PrEP Initiation and Adherence Among Transgender and Gender Non-Binary Individuals in Southern California.
    Watson CW; Pasipanodya E; Savin MJ; Ellorin EE; Corado KC; Flynn RP; Opalo C; Lampley E; Henry BL; Blumenthal J; Bolan R; Morris S; Moore DJ
    AIDS Educ Prev; 2020 Dec; 32(6):472-485. PubMed ID: 33779208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam.
    Doan AH; Vu CMH; Nguyen TT; Green KE; Phan HTT; Janamnuaysook R; Vu BN; Le TM; Do KQ; Tran TT; Ngo TM; Basu L; Tran LK; Humeau Z
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25996. PubMed ID: 36225133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review.
    Dang M; Scheim AI; Teti M; Quinn KG; Zarwell M; Petroll AE; Horvath KJ; John SA
    AIDS Patient Care STDS; 2022 Jun; 36(6):236-248. PubMed ID: 35687813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.
    Cahill SR; Keatley J; Wade Taylor S; Sevelius J; Elsesser SA; Geffen SR; Wang T; Mayer KH
    AIDS Care; 2020 May; 32(5):585-593. PubMed ID: 31482726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
    Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
    AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
    Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women.
    Sevelius JM; Keatley J; Calma N; Arnold E
    Glob Public Health; 2016; 11(7-8):1060-75. PubMed ID: 26963756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study.
    Janamnuaysook R; Guo Y; Yu YJ; Phanuphak N; Kawichai S; MacDonell K; Jupimai T; Rongkavilit C; Wang B
    Sex Health; 2024 Jan; 21():. PubMed ID: 38219741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
    Kenison TC; Badenhop B; Safo S
    AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Gaps of HIV Knowledge Among Transgender Young Adults: A Pilot Interview Study.
    DeMaio DM; Barerra EP; Post J; Boskey ER; Guss CE
    AIDS Educ Prev; 2024 Aug; 36(4):229-243. PubMed ID: 39189961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitators of PrEP Persistence among Black and Latinx Transgender Women in a PrEP Demonstration Project in Southern California.
    Storholm ED; Ogunbajo A; Nacht CL; Opalo C; Horvath KJ; Lyman P; Flynn R; Reback CJ; Blumenthal J; Moore DJ; Bolan R; Morris S
    Behav Med; 2024; 50(1):63-74. PubMed ID: 35993278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-exposure prophylaxis for transgender women and men who have sex with men: qualitative insights from healthcare providers, community organization-based leadership and end users in coastal Kenya.
    Kimani M; Sanders EJ; Chirro O; Mukuria N; Mahmoud S; Rinke de Wit TF; Graham SM; Operario D; van der Elst EM
    Int Health; 2022 May; 14(3):288-294. PubMed ID: 34325469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    Sevelius JM; Poteat T; Luhur WE; Reisner SL; Meyer IH
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):437-442. PubMed ID: 32692101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-Based Violence and Post-traumatic Stress Disorder Symptoms Predict HIV PrEP Uptake and Persistence Failure Among Transgender and Non-binary Persons Participating in a PrEP Demonstration Project in Southern California.
    Storholm ED; Huang W; Ogunbajo A; Horvath KJ; Reback CJ; Blumenthal J; Moore DJ; Flynn RP; Bolan RK; Corado KC; Morris SR
    AIDS Behav; 2023 Feb; 27(2):745-759. PubMed ID: 36053404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
    Malone J; Reisner SL; Cooney EE; Poteat T; Cannon CM; Schneider JS; Radix A; Mayer KH; Haw JS; Althoff KN; Wawrzyniak AJ; Beyrer C; Wirtz AL;
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):10-18. PubMed ID: 34397742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.